2020-06-11T15:06:00Zhttps:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi
oai:pubmedcentral.nih.gov:27901032010-01-07ijmspmc-open
Int J Mol Sci ijms International Journal of Molecular Sciences 1422-0067 Molecular Diversity Preservation International (MDPI) PMC2790103 PMC2790103 2790103 20057940 10.3390/ijms10104198 ijms-10-04198 Review Regulation of Enzyme Activity through Interactions with Nanoparticles Wu Zhaochun 1 Zhang Bin 2 Yan Bing 2 3 * School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, China St. Jude Children’s Research Hospital, Memphis, TN 38105, USA Author to whom correspondence should be addressed; E-Mail: bing.yan@stjude.org; Tel.: +1-901-5952797; Fax: +1-901-5955715. 10 2009 20 11 2009 10 10 4198 4209 18 8 2009 15 9 2009 21 9 2009 © 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. 2009 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).

The structure and function of an enzyme can be altered by nanoparticles (NPs). The interaction between enzyme and NPs is governed by the key properties of NPs, such as structure, size, surface chemistry, charge and surface shape. Recent representative studies on the NP-enzyme interactions and the regulation of enzyme activity by NPs with different size, composition and surface modification are reviewed.

enzyme activity regulation nanoparticle
Introduction

The regulation of the protein activity plays an important role in modulating cellular processes such as signal transduction, DNA replication, and metabolism [1,2]. Protein dysfunction is related to human diseases and disorders [3–7], and our ability to regulate enzyme functions and protein-protein interactions provides a promising strategy for therapy. Nanoparticles (NPs) have some advantages over small organic molecules. First, NPs have large specific surface areas for adequate protein binding and biological interactions [1,8]. Second, NP can enter cells easily [10], in contrast to some small molecules and biological molecules. Third, there has been considerable progress in the synthesis of NPs with well controlled dimensions, geometry, and surface properties [9], to complement the structural complexity of proteins [11,12]. Recent developments in nano materials offer a new pathway for controlling protein behavior through surface interactions.

In the past few years, NPs with different dimensions, composition and surface modification were investigated to understand their interactions with proteins. The hydrophobic interaction [13–15], π-π stacking [16–18] and electrostatic interaction [19–21] have been attributed to be major mechanisms of NP-protein interactions. These mechanisms often coexist.

This review, by summarizing recent research on nanoparticle/protein interactions, intends to emphasize the importance of such interactions in biological systems that may cause nanotoxicity issues, and the potential of such molecular recognition events in biomedical applications such as the diagnosis and treatment of human diseases.

Effects of Mixed Monolayer Protected Nano Clusters (MMPCs)

Mixed monolayer protected gold clusters (MMPCs) provide an effective scaffold for biomolecular binding. MMPCs were synthesized using the Brust reduction and Murray place-displacement reaction [24] to fabricate additional functionalized thiols ended with carboxylate groups and amino groups, respectively [MMPCs 1, 2, and 3 in Figure 1(c) featuring a 2-nm gold core, with an overall diameter of 6 nm] [25]. These particles exhibited different effects on chymotrypsin (ChT) activity. The cationic MMPC 3 had no inhibition, while the anionic MMPC 1 and 2 were effective inhibitors of ChT because of the electrostatic complementarity between the carboxylate end groups and the hole of cationic residues located around the periphery of the active site, as shown in Figure 1(b). Complete inhibition was observed at a 1:5 nanoparticle to ChT ratio.

The activity assay indicated that the inhibition of ChT by MMPCs was controlled by a two-stage mechanism featuring a fast reversible inhibition, followed by a slower irreversible process. Circular dichroism measurements of the complex demonstrated an almost complete denaturation of the enzyme over time. Dynamic light scattering studies confirmed that inhibition proceeded without substantial MMPC aggregation. The electrostatic nature of the engineered interactions provides a level of selectivity: little or no inhibition of functions of elastase, β-galactosidase, or cellular retinoic acid binding protein by MMPC was observed.

The “irreversible” inhibition of ChT can be reversed through modification of the anionic MMPC surface by the addition of cationic surfactants [26]. Four derivatives of trimethylamine-functionalized surfactants were used to modifiy the gold nanoparticles (GNPs) with carboxylate endgroups (4, 5, 6 and 7 in Figure 2c, featuring a 2-nm gold core, with an overall diameter of 6 nm). Up to 50% of original ChT activity was rescued upon long-chain surfactant addition. Dynamic light scattering studies demonstrated that ChT released from the nanoparticle surface and the conformation characterization of the rescued ChT by fluorescence and fluorescence anisotropy indicated that ChT regained a high degree of native structure upon surfactant addition. The proposed mechanism of the ChT release: the MMPC 5 and MMPC 6 can elicit ChT release by interaction and/or partial displacement of the anionic monolayer. The MMPC 4, a bilayer-type structure, can release ChT when it envelops the MMPC surface, as shown schematically in Figure 3. The noncovalent nature of the irreversible inhibition of ChT shows that the attenuation of the interactions the MMPC and protein could provide a means of rescuing enzyme activity.

Influence of the Size of NP on the Activity of Adsorbed Enzymes

The size of NPs is one of the key parameters that influence the interaction between protein and NPs. Silica NPs with different diameters (4, 20 and 100 nm) were used to investigate the size influence on the structure and enzymatic activity of adsorbed lysozyme, whose dimensions are comparable in size to the 4 nm NPs [27]. Both adsorption patterns and protein structure and function are strongly dependent on the size of the NPs. The formation of molecular complexes is observed for adsorption onto 4-nm silica. The CD results proved that the loss in α-helix content is strongly dependent on the size of the NPs. The great loss of α helicity was observed for the lysozyme adsorbed onto larger NPs. The activity of lysozyme adsorbed onto silica NPs is lower than that of the free protein, and the fraction of activity lost correlates well with the decrease in α-helix content. These results indicate that the size of the NP, perhaps because of the contributions of surface curvature, influences adsorbed protein structure and function (Figure 4).

The same phenomenon was also observed when ribnuclease A [28] and human carbonic anhydrase [29] were absorbed onto silica NPs surfaces with different sizes. Urea denaturation analyses showed that the thermodynamic stability of ribnuclease A was decreased upon adsorption on to the NPs, with greater decrease on larger NPs. Therefore, the larger NPs tend to cause unfolding of adsorbed proteins [28].

Conformational Changes as a Result of NP/Protein Binding

Applications from diagnostics to drug delivery require that enzymes retain their native structures and activities. Conjugates of acid-treated SWNTs with three functionally unrelated enzymes horseradish peroxidase, subtilisin Carlsberg, and chicken egg white lysozymes were found to be soluble in aqueous solutions [30]. Enzyme kinetics revealed that these enzymes retained a high fraction of their native structures and activities. The SWNT-enzyme conjugates were also more stable in guanidine hydrochloride (GdnHCl) and at elevated temperatures relative to their solution counterparts. These studies demonstrate the enhanced stability of SWNT-enzyme preparations relative to free enzymes in solution. Such water-soluble enzyme-nanotube conjugates may be useful in a wide range of applications.

Two enzymes, α-chymotrypsin and soybean peroxidase, were adsorbed onto the single-walled carbon nanotubes. α-chymotrypsin retained only 1% of its native activity while soybean peroxidase retained 30% of its native activity. The FT-IR spectroscopy revealed that substantial secondary structural perturbation is occurred after ChT binding to the SWNTs. This phenomenon was caused by the hydrophobic interaction between the SWNTs and the proteins. Soybean peroxidase had a hydrophobic pocket that bound to SWNTs leaving the active site exposed to the solvent to bind substrate. Denaturation of ChT was responsible for low activity (Figure 5) [31]. If the nanomaterial surface is modified with hydrophilic polymers such as oligomeric PEG moieties, the interactions of NPs and proteins may be alleviated [32].

Regulation of Enzyme Function by Surface-Modified NPs

Compared with traditional materials, NPs have a larger surface area that can be modified with organic molecules through covalent or non-covalent modifications to form functionalized NPs. The suitably functionalized NPs possess the abilities that prinstine NPs do not have, such as preventing non-specific bindings and recognizing specific biomacromolecules. In this way, enzyme activities can be specifically regulated when bound to surface modified NPs.

Three silicon nanowires (SiNW) [33], unmodified silicon nanowires (SiNW-SiO2), SiNWs functionalized with carboxylic groups (SiNW-COOH) and highly reactive hydrogen modified SiNW (SiNW-H) were synthesized to investigate their affect on restriction endonucleases and Taq DNA polymerase. The PCR results showed that the inhibition of enzyme activity was determined by the functional groups on SiNWs in the order SiNW-H > SiNW-COOH > SiNW-SiO2.

Specific NP/protein binding provides a better opportunity for regulating enzyme functions. Carbonic anhydrase inhibitor 8 linked to gold NPs (GNP-8, with an average particle size of 3.3 nm, which corresponds to 720–724 Au atoms) showed excellent CA IX inhibition of the tumer-associated isoform and selectivity over hCA I and II (Table 1, Figure 6) [34] due to the fact that their binding pocket contains different residues. Table 1 listed the inhibition of CA I, II and IXa by acetazolamide (AZA), sulfonamides 8, 9, GNP-8 and GNP-9. It has been also shown that molecules such as antibodies, which can recognize protein specifically, can be linked to NPs to recognize proteins through specific antibody-antigen interactions [35,36].

We have synthesized a novel surface-modified multi-wall carbon nanotube combinatorial library containing 80 members by using in silico design and combinatorial synthesis [37]. By screening the library we discovered MWNTs with reduced protein binding, reduced cytotoxicity, and immune response. The ChT enzymatic activity and fluorescent quenching were measured by incubating ChT with functionalized multiwalled carbon nanotube (f-MWNTs, were synthesized by chemical vapor deposition. The purity was 95% and the catalyst residue was less than 0.2%. They are 40 nm in diameter and the length is 500–2,000 nm) (Figure 7A). By screening the library [38], we discovered four f-MWNTs that can bind to the catalytic site of ChT site-specifically and inhibit its enzymatic activity competitively (Figure 7B). Our results demonstrated that specific recognition of ChT and regulation of its functions by surface-modified MWNT.

Fine Tuning of NP/Protein Interactions

CdSe particles modified with thioalkylated oligo(ethylene glycol) and chain-end carboxylate were synthesized [39]. The study of the interactions between CdSe NPs and chymotrypsin revealed three levels of inhibition: (1) protein inhibition and denaturation with NP-10, (2) no protein binding with NP-11, and (3) inhibition and retention of the protein structure with NP-12. The NP-10 with alkanethiol-carboxylate functionalized can bind, inhibit, and denaturate of ChT because of the hydrophobic interactions. The NP-11, lacking of the carboxylate recognition element, was inert in protein binding. The NP-12, modified with tetraethylene glycol spacer between the alkyl chain and recognition element, can inhibit ChT reversibly because of the electrostatic interaction between the particle and protein, but prevents hydrophobic interactions caused by the interior alkyl chain (Figure 8).

In order to explore how the linkages between recognition elements and NP core affect the NP/enzyme interacion. A series of l-amino acid functionalized GNPs with oligo (ethylene glycol) tethers of varying length were studied. It has been shown that amino acid side chains can maintain the ChT structure while the alkyl chains denature the protein as a result of nonspecific hydrophobic interactions [40].

Structure diversity can also be generated by introducing amino acids in the surface modification. The hydrophobic interaction and the complementary electrostatic interactions between Au nanoparticles with l-amino acids as endgroups and ChT also plays an important role in regulating ChT activity [41].

Protein-protein recognition is a key aspect of the complex cellular functions, such as apoptosis and angiogenesis. Control over interprotein recognition holds the potential in therapeutic applications. Thiolates with biocompatible PEG linker and trimethyl-amine end group were used to functionalize Au nanoparticles. And it can inhibit interactions between cytochrome c and cytochrome c perxidase in the low nM concentration range [42].

Conclusions

Enzyme dysfunction is related to human diseases. It is desirable to be able to regulate enzyme conformation and function. Nano sensors incorporating enzymes also require that protein conformation is not altered, further emphasizing the importance of protein regulation. NPs can be selected to specifically bind enzymes and control their functions after surface modifications. Such NP/protein interactions can be fine-tuned to maintain protein structure or alter it on purpose.

This work was supported by Shandong University, the American Lebanese Syrian Associated Charities (ALSAC) and St. Jude Children’s Research Hospital.

References Gadek TR Nicholas JB Small molecule antagonists of proteins Biochem. Parmacol 2003 65 1 8 Toogood PL Inhibition of protein-protein association by small molecules: Approaches and progress J. Med. Chem 2002 45 1543 1558 11931608 Armbruster BN Banik SSR Guo CH Smith AC Counter C N-Terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo Mol. Cell. Biol 2001 21 7775 7786 11604512 Shultz MD Ham Y-W Lee S-G Davis DA Brown C Chemielewski J Small-molecule dimerization inhibitors of wild-type and mutant HIV protease: A focused library approach J. Am. Chem. Soc 2004 126 9886 9887 15303839 Longthorne VL Williams GT Caspase activity is required for commitment to fas-mediated apoptosis EMBO J 1997 16 3805 3812 9233790 Singh I Biochemistry of peroxisomes in health and disease Mol. Cell. Biochem 1997 167 1 29 9059978 D’Armiento J Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction Trends Cardiovasc. Med 2002 12 97 101 12007733 Erkizan HV Kong YL Merchant M Schlottmann S Barber-Rotenberg JS Yuan LS Abaan OD Chou T-H Dakshanamurthy S Brown ML Ueren A Toretsky JA A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing’s sarcoma Nature Med 2009 15 750 757 19584866 Lo Conte L Chothia C Janin J The atomic structure of protein-protein recognition sites Mol. Bio 1999 285 2177 2198 Porter AE Gass M Muller K Skepper JN Midgley PA Welland M Direct imaging of single-walled carbon nanotubes in cells Nat. Nanotechnol 2007 2 713 717 18654411 Mu QX Liu W Xing YH Zhou HY Li ZW Zhang Y Ji LH Wang F Si ZK Zhang B Yan B Protein binding by functionalized multiwalled carbon nanotubes is governed by the surface chemistry of both parties and the nanotube diameter J. Phys. Chem. C 2008 112 3300 3307 Peng XG Manna L Yang WD Wickham J Scher E Kadavanich A Alivisatos AP Shape control of CdSe nanocrystals Nature 2000 404 59 61 10716439 Strano MS Dyke CA Usrey ML Barone PW Allen MJ Shan HW Kittrell C Hauge RH Tour JM Smalley RE Electronic structure control of single-walled carbon nanotube functionalization Science 2003 301 1519 1522 12970561 You CC Arvizo RR Rotello VM Regulation of α-chymotrypsin activity on the surface of substrate-functionalized gold nanoparticles Chem Comm 2006 2905 2907 17007412 Erlanger BF Chen BX Zhu M Brus L Binding of an anti-fullerene IgG monoclonal antibody to single wall carbon nanotubes Nano Lett 2001 1 465 467 Lin Y Allard LF Sun Y-P Protein-affinity of single-walled carbon nanotubes in water J. Phy. Chem. B 2004 108 3760 3764 Stina L Lynch I Eva T Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamine/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity Nano Lett 2007 7 914 920 17335269 Li XJ Chen W Zhan QW Dai LM Direct measurements of interactions between polypeptides and carbon nanotubes J. Phys. Chem. B 2006 110 12621 12625 16800593 Irle S Zheng GS Elstner M Morokuma K Formation of fullerene molecules from carbon nanotubes: A quantum chemical molecular dynamics study Nano Lett 2003 3 465 470 Chen RJ Zhang YG Wang DW Dai HJ Noncovalent sidewall functionalization of single-walled carbon nanotubes for protein immobilization J. Am. Chem. Soc 2001 123 3838 3839 11457124 Hong R Emrick T Rotello VM Monolayer-controlled substrate selectivity using noncovalent enzyme-nanoparticle conjugates J. Am. Chem. Soc 2004 126 13572 13573 15493887 You C-C Arvizo RR Rotello VM Regulation of α-chymotrypsin activity on the surface of substrate-functionalized gold nanoparticles Chem Comm 2006 2905 2907 17007412 Bradley K Briman M Star A Gruner G Charge transfer from adsorbed proteins Nano Lett 2004 4 253 256 Hostetler MJ Green SJ Stoke JJ Murray RW Monolayers in three dimensions: Synthesis and electrochemistry of ω-functionalized alkanethiolate-stabilized gold clusters compound J. Am. Chem. Soc 1996 118 4212 4213 Fischer NO Mclntosh CM Simard JM Rotello VM Inhibition of chymotrypsin through surface binding using nanoparticle-based receptors Proc. Nat. Acad. Sci. USA 2002 99 5018 5023 11929986 Fischer NO Verma A Goodman CM Simard JM Rotello VM Reversible “irreversible” inhibition of chymotrypsin using nanoparticle receptors J. Am. Chem. Soc 2003 125 13387 13391 14583034 Vertegel AA Siegel RW Dordick JS Silica nanoparticle size influences the structure and enzymatic activity of adsorded lysozyme Langmuir 2004 20 6800 6807 15274588 Shang W Nuffer HH Dordick JS Siegel RW Unfolding of ribonuclease A on silica nanoparticle surfaces Nano Lett 2007 7 1991 1995 17559285 Lundqvist M Sethson I Jonsson BH Protein adsorption onto silica nanoparticles: Conformational changes depend on the particle’s curvature and the protein stability Langmuir 2004 20 10639 10647 15544396 Asuri P Bale SS Pangule RC Shah DA Kane RS Dordick JS Structure, function, and stability of enzymes covalently attached to single-walled carbon nanotube Langmuir 2007 23 12318 12321 17944500 Karajanagi SS Vertegel AA Kane RS Dordick JS Structure and function of enzymes adsorbed onto single-walled carbon nanotubes Langmuir 2004 20 11594 11599 15595788 Lin Y Allard LF Sun YP Protein-affinity of single-walled carbon nanotubes in water J. Phys. Chem. B 2004 108 3760 3764 Yi CQ Fong C-C Chen WW Qi SJ Lee S-T Yang MS Inhibition of biochemical reactions by silica nanowires through modulating enzyme activities ChemBioChem 2007 8 1225 1229 17566125 Stiti M Cecchi A Rami M Abdaoui M Barragan-Montero V Scozzafava A Guari Y Winum J-Y Supuran CT Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic lsozymes I and II J. Am. Chem. Soc 2008 130 16130 16131 18989963 Lu FS Gu LR Meziani MJ Wang X Luo PJ Veca LM Cao L Sun Y-P Advances in bioapplications of carbon nanotubes Adv. Mater 2009 21 139 152 Tara Elkin T Jiang XP Taylor S Lin Y Gu LR Yang H Brown J Collins S Sun Y-P Immuno-carbon nanotubes and recognition of pathogens ChemBioChem 2005 6 640 643 15742378 Zhou HY Mu QX Gao NN Liu AF Xing YH Gao SL Zhang Q Qu GB Chen YY Liu G Zhang B Yan B A nano-combinatorial library strategy for the discovery of nanotubes with reduced protein-binding, cytotoxicity, and immune response Nano Lett 2008 8 859 865 18288815 Zhang B Xing YH Li ZW Zhou HY Mu QX Yan B Functionalized carbon nanotubes specifically bind to chymotrypsin catalytic site and regulate its enzymatic function Nano Lett 2009 9 2280 2284 19408924 Hong R Fishcer NO Verma A Goodman CM Emrick T Retello VM Control of protein structure and function through surface recognition by tailored nanopartcile scaffolds J. Am. Chem. Soc 2004 126 739 743 14733547 You C-C De M Rotello VM Contrasting effect of exterior and interior hydrophobic moieties in the complexation of amino acid functionalized gold clusters with α-chymotrypsin Org. Lett 2005 7 5685 5688 16321022 You C-C De M Han G Rotello VM Tunable inhibition and denaturation of α-chymotrypsin with amino acid-functionalized gold nanoparticles J. Am. Chem. Soc 2005 127 12873 12881 16159281 Bayraktar H Ghosh PS Rotello VM Knapp MJ Disruption of protein-protein interactions using nanopartciles: Inhibition of cytochrome C peroxidase Chem Commun 2006 1390 1392

(a) Space-filling model of ChT. Surface binding of the proteins by anionic MMPCs focuses on the ring of cationic residues situated around the active site, functionally significant residues are noted. (b) Relative sizes of ChT and MMPC 1. (c) Anionic MMPCs 1 and 2 and cationic control 3 (reproduced with permission from [25] © 2004, National Academy of Sciences, U.S.A).

(a) Space-filling model of ChT. Active site (yellow) is surrounded by a ring of cationic residues (blue). (b) Amphiphilic MMPCs with anionic functional groups (red) in their terminals can interact with ChT via electrostatic complementarity. (c) Four derivatives of trimethylamine-functionalized surfactant used for surface modification of MMPC anionic monolayer. (d) Monolayer composition of AuCOOH (reproduced with permission from [26] © 2003, American Chemical Society).

Proposed mechanism of ChT rescue. The surfactants with thiol 5 and alcohol 6 at their terminals have the ability to elict ChT release by interaction and/or partial displacement of the anionic monolayer. C11 alkane 4 forms a bilayer-like structure, causing release of the ChT (red = anionic; blue = cationic) (reproduced with permission from [26] © 2003, American Chemical Society).

Schematic of lysozyme adsorption on silica particles with different sizes. Stronger protein particle interactions exist in the case of larger nanoparticles, resulting in more protein unfolding and less enzymatic activity (reproduced with permission from [27] © 2004, American Chemical Society).

(a) PDB structure of SBP showing the hydrophobic pocket. Hydrophobic and hydrophilic residues are shown in blue and yellow, respectively, while the asparagines residues that are glycosylated are shown in green and the heme is shown in red. (b) A schematic hypothesizing the adsorption of SBP onto SWNTs via the hydrophobic pocket on SBP (reproduced with permission [31] © 2004, American Chemical Society).

Structure of the acetazolamide AZA, the new sulfonamides 8, 9, GNP-8 and GNP-9.

(a) The quenching of ChT’s fluorescence (left) and inhibition of its enzymatic activity (right) by f-MWNTs. (b) Models showing different ways f-MWNTs bind to ChT (reproduced with permission from [38] © 2004, American Chemical Society).

Ligands used for CdSe nanoparticles, and schematic depiction of protein-nanoparticle interactions (reproduced with permission from [39] © 2004, American Chemical Society).

CA inhibition data against isoforms CA I, II and IX a

Kib (nM)
Compound hCA I hCA II hCA IX
AZA 250 ± 12 12 ± 1 25 ± 1
8 214 ± 9 230 ± 10 41 ± 2
GNP-8 581 ± 18 (128) 451 ± 21 (116) 32 ± 2 (2.4)
9 >50,000 >50,000 >50,000
GNP-9 28,550 30,400 31,050

Au 32,000 31,600 29,560

Reproduced with permission from [34] © 2003, American Chemical Society.

Inhibition constants (Ki) are obtained by nonlinear least-squares methods after being incubated with compound 15min.Data in parentheses show the inhibition constants when enzyme and inhibitor were incubated for 2 h.